154 related articles for article (PubMed ID: 34733616)
1. Novel molecular panel for evaluating systemic inflammation and survival in therapy naïve glioma patients.
Gandhi P; Shrivastava R; Garg N; Sorte SK
World J Clin Oncol; 2021 Oct; 12(10):947-959. PubMed ID: 34733616
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the potential of circulating hTERT levels in glioma: can plasma levels serve as an independent prognostic marker?
Gandhi P; Khare R; Garg N
J Neurooncol; 2017 Nov; 135(2):255-261. PubMed ID: 28756592
[TBL] [Abstract][Full Text] [Related]
3. Can a signature molecular-profile define disparate survival in BRAF-positive Gliosarcoma and identify novel targets for therapeutic intervention?
Gandhi P; Khare R; Garg N; Mishra J
J Cancer Res Ther; 2022; 18(1):224-230. PubMed ID: 35381788
[TBL] [Abstract][Full Text] [Related]
4. Systemic and local immunosuppression in glioblastoma and its prognostic significance.
Stepanenko AA; Sosnovtseva AO; Valikhov MP; Chernysheva AA; Abramova OV; Pavlov KA; Chekhonin VP
Front Immunol; 2024; 15():1326753. PubMed ID: 38481999
[TBL] [Abstract][Full Text] [Related]
5. Circulatory YKL-40 & NLR: Underestimated Prognostic Indicators in Diffuse Glioma.
Gandhi P; Khare R; VasudevGulwani H; Kaur S
Int J Mol Cell Med; 2018; 7(2):111-118. PubMed ID: 30276166
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of preoperative inflammatory markers among different molecular subtypes of lower-grade glioma.
Qi Z; Cai J; Meng X; Cai S; Tang C; Lang L
J Clin Neurosci; 2022 Feb; 96():180-186. PubMed ID: 34802893
[TBL] [Abstract][Full Text] [Related]
7. Preoperative neutrophil-lymphocyte ratio correlated with glioma grading and glioblastoma survival.
Weng W; Chen X; Gong S; Guo L; Zhang X
Neurol Res; 2018 Nov; 40(11):917-922. PubMed ID: 30074469
[TBL] [Abstract][Full Text] [Related]
8. Indoleamine 2,3-dioxygenase gene expression and kynurenine to tryptophan ratio correlation with nasopharyngeal carcinoma progression and survival.
Souissi S; Ghedira R; Macherki Y; Ben-Haj-Ayed A; Gabbouj S; Remadi Y; Sfar I; Chadli Z; Aouam K; Hassine M; Bouaouina N; Zakhama A; Hassen E
Immun Inflamm Dis; 2022 Sep; 10(9):e690. PubMed ID: 36039641
[TBL] [Abstract][Full Text] [Related]
9. Measuring the Systemic Inflammatory Response to On- and Off-Pump Coronary Artery Bypass Graft (CABG) Surgeries Using the Tryptophan/Kynurenine Pathway.
Farouk A; Hamed RA; Elsawy S; Abd El Hafez NF; Moftah FM; Nassar MAY; Gabra FA; Saleem TH
J Invest Surg; 2022 Aug; 35(8):1621-1625. PubMed ID: 35694760
[No Abstract] [Full Text] [Related]
10. Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461.
Li G; Shen J; Cao J; Zhou G; Lei T; Sun Y; Gao H; Ding Y; Xu W; Zhan Z; Chen Y; Huang H
J Exp Clin Cancer Res; 2018 Apr; 37(1):78. PubMed ID: 29631594
[TBL] [Abstract][Full Text] [Related]
11. Isocitrate dehydrogenase 1 mutation is associated with reduced levels of inflammation in glioma patients.
Auezova R; Ivanova N; Akshulakov S; Zhetpisbaev B; Kozhakhmetova A; Ryskeldiyev N; Mustafin K; Teltayev D; Auezova L
Cancer Manag Res; 2019; 11():3227-3236. PubMed ID: 31114362
[No Abstract] [Full Text] [Related]
12. The immune-kynurenine pathway in social anxiety disorder.
Butler MI; Long-Smith C; Moloney GM; Morkl S; O'Mahony SM; Cryan JF; Clarke G; Dinan TG
Brain Behav Immun; 2022 Jan; 99():317-326. PubMed ID: 34758380
[TBL] [Abstract][Full Text] [Related]
13. Kynurenine serves as useful biomarker in acute, Long- and Post-COVID-19 diagnostics.
Bizjak DA; Stangl M; Börner N; Bösch F; Durner J; Drunin G; Buhl JL; Abendroth D
Front Immunol; 2022; 13():1004545. PubMed ID: 36211365
[TBL] [Abstract][Full Text] [Related]
14. Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer.
Sirera R; Bremnes RM; Cabrera A; Jantus-Lewintre E; Sanmartín E; Blasco A; Del Pozo N; Rosell R; Guijarro R; Galbis J; Sánchez JJ; Camps C
J Thorac Oncol; 2011 Feb; 6(2):286-90. PubMed ID: 21252717
[TBL] [Abstract][Full Text] [Related]
15. Increased kynurenine plasma concentrations and kynurenine-tryptophan ratio in mild-to-moderate chronic obstructive pulmonary disease patients.
Zinellu A; Fois AG; Zinellu E; Sotgiu E; Sotgia S; Arru D; Mangoni AA; Carru C; Pirina P
Biomark Med; 2018 Mar; 12(3):229-237. PubMed ID: 29506391
[TBL] [Abstract][Full Text] [Related]
16. The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients.
Cheng H; Luo G; Lu Y; Jin K; Guo M; Xu J; Long J; Liu L; Yu X; Liu C
Pancreatology; 2016; 16(6):1080-1084. PubMed ID: 27665172
[TBL] [Abstract][Full Text] [Related]
17. Cell-free circulating plasma hTERT mRNA is a useful marker for prostate cancer diagnosis and is associated with poor prognosis tumor characteristics.
March-Villalba JA; Martínez-Jabaloyas JM; Herrero MJ; Santamaria J; Aliño SF; Dasí F
PLoS One; 2012; 7(8):e43470. PubMed ID: 22916267
[TBL] [Abstract][Full Text] [Related]
18. Assessment of tryptophan and kynurenine as prognostic markers in patients with SARS-CoV-2.
Michaelis S; Zelzer S; Schnedl WJ; Baranyi A; Meinitzer A; Enko D
Clin Chim Acta; 2022 Jan; 525():29-33. PubMed ID: 34902346
[TBL] [Abstract][Full Text] [Related]
19. Peripheral kynurenine/tryptophan ratio is not a reliable marker of systemic indoleamine 2,3-dioxygenase: A lesson drawn from patients on hemodialysis.
Chen Y; Xie Z; Xiao C; Zhang M; Li Z; Xie J; Zhang Y; Zhao X; Zeng P; Mo L; Liang X; Shi W
Oncotarget; 2017 Apr; 8(15):25261-25269. PubMed ID: 28445957
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of inflammation markers in postoperative gliomas with or without adjuvant treatments.
Luo Y; Deng R; Zhong Q; Luo D; Li X; Chen X; Tao S; Feng Z; Jiayi L; Huang Y; Li J; Liu W
Medicine (Baltimore); 2021 Jun; 100(25):e26437. PubMed ID: 34160435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
